Skip to main content
. 2023 Dec 21;67(5):560–567. doi: 10.3340/jkns.2023.0214

Table 2.

Univariate analysis of the prognostic factors related to the PFS after 2-day fraction GKRS for large brain metastasis

Prognostic factor PFS (days) p-value
Tumor volume, 20 mL 0.955
 ≤20 mL 239±32
 >20 mL 230±32
Tumor volume, 15 mL 0.247
 ≤15 mL 199±3
 >15 mL 239±37
50% isodose volume 0.839
 ≤18.8 mL 230±29
 >18.8 mL 239±36
70% isodose volume 0.622
 ≤7.5 mL 238±48
 >7.5 mL 235±26
80% isodose volume 0.846
 ≤3.3 mL 239±7
 >3.3 mL 197±32
Peri-GKRS systemic treatment 0.741
 Yes 239±50
 No 230±29
Previous brain irradiation 0.019
 Yes 85±55
 No 238±4
Lung cancer primary 0.041
 Yes 435±153
 No 230±28

PFS : progression free survival, GKRS : Gamma Knife radiosurgery